Eric Mittelmann, MD
Neurology · Paramus, NJNPI 1215291240
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,750 of the $40,881 with a category attached, or 99.7%. Applied Therapeutics, Inc. accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $22,500 and has fallen 99.9% since, to $21 in 2025. Among neurology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $2555.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Therapeutics, Inc.$41K
- Sunovion Pharmaceuticals Inc.$37
- SK Life Science, Inc.$31
- Vertical Pharmaceuticals, LLC$26
- Otsuka America Pharmaceutical, Inc.$21
- UCB, Inc.$15
What the payments were for
- Consulting fees$40,750100%
- Food & beverage$1310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Therapeutics, Inc. | 8 | $40,750 |
| Sunovion Pharmaceuticals Inc. | 3 | $37 |
| SK Life Science, Inc. | 2 | $31 |
| Vertical Pharmaceuticals, LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $15 |
How this compares
$40,881 in reported general payments places this provider in the 90th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 11 | $92,524 |
| Gabapentin | 13 | $342 |
| Prednisone | 13 | $271 |
Paid to pharmacies, not to this prescriber.
Other neurology in Paramus
- Yeva FernandezParamus$67K
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
- Ashish KapoorBayonne$329K
- Mario VukicHackensack$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.